Clinical Trials Logo

Clinical Trial Summary

The purpose of this clinical trial is to study the efficacy and safety of naltrexone implants as relapse prevention for patients that are completing treatment for opiate addiction in inpatient (or similarly controlled) settings. Participants in the naltrexone experimental group are prematched in a pairwise fashion with other patients who do not want a naltrexone implant during the first six months after ending inpatient treatment, but who reiceive treatment as usual (TAU) from the Norwegian healthcare system.

The hypotheses are that quality of life, depression, opioid use, will be significantly better in the naltrexone group compared to the non at 6-, 12-, and 18-month follow-up.

We also hypothesize that the implants can prevent death from opioid overdose up to 6 months after commenced treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00269607
Study type Interventional
Source University of Oslo
Contact
Status Terminated
Phase Phase 2/Phase 3
Start date May 2005
Completion date December 2006

See also
  Status Clinical Trial Phase
Terminated NCT00772785 - Study of Probuphine in Patients With Opioid Dependence Phase 3
Completed NCT00591617 - Optimizing Outcomes Using Suboxone for Opiate Dependence N/A
Completed NCT01075971 - Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) Phase 2
Completed NCT00913484 - Disulfiram for Cocaine Abuse in Buprenorphine Treatment Phase 2
Completed NCT01262261 - Re-Treatment Study of Probuphine in Opioid Addiction Phase 3
Completed NCT00577005 - Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients Phase 2
Completed NCT01806389 - A Study of Breastfeeding in Buprenorphine Maintained Women N/A
Completed NCT00955162 - Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") Phase 4
Completed NCT00727675 - Chronic Pain and Opioid Dependence Assessment and Treatment N/A
Completed NCT00742170 - Transdermal Electroacupuncture for Opioid Detoxification Phase 1/Phase 2
Completed NCT01114308 - A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction Phase 3
Completed NCT00877591 - Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications Phase 1